Displaying 51 - 60 of 321
Causes of blood cancer - What we know - Innovation and Research Webcast Series 2023
Updated:
In this presentation, Dr. John Dick, one of Canada’s pioneering scientists in the field of “cancer stem cells”, will explain how his research into the causes of blood cancers holds the promise for improved treatments and quality of life for Canadians affected by blood cancers.
Diagnosis and tests, Leukemia, Research
How your gut health can improve your blood cancer treatment and quality of life: Webcast
Updated:
In this "Innovation in Research" webcast recording, you will learn about the community of microbes (bacteria, fungi, viruses and their genes) living within our digestive tracts, known as the “gut microbiome,” and how it can play a role in blood cancer treatment and…
Research, Treatment and side effects
Understanding ribonucleic acid (RNA) and its role in leukemia: 2024 Leukemia Conference
Updated:
RNA is more than just DNA's lesser-known cousin. Dr. Katherine Borden, Professor, Pathology, Cell Biology at the Institute for Research in Immunology and Cancer, University of Montreal and Dr. Sarit Assouline, chief of the Division of Hematology at the JGH and Senior…
Leukemia, Research
Artificial Intelligence and the Future of Blood Cancers webcast
Updated:
In this 2025 webcast, four scientists funded by the LLSC's AI Catalyst Grant talk about their work investigating how AI / machine learning can speed up discovery and detection of blood cancers in their research work. Moderated by Dr. Paul O'Connell, LLSC Research…
Research
Understanding multiple myeloma
Updated:
Multiple myeloma, or MM, is a type of blood cancer that starts in the bone marrow. Multiple myeloma affects plasma cells, a type of white blood cell that normally fights infection, turning healthy cells into cancer cells that can damage blood, bones and kidneys.
Myeloma
Chronic Lymphocytic Leukemia (CLL) Treatment Discussion Guide
Updated:
Beyond active surveillance (the ‘watch and wait approach’) there are several CLL treatments to consider. Each treatment has different features and side effects. It is important to be comfortable with the CLL treatment you choose.
Leukemia
Problems sleeping during and after treatment
Updated:
Cancer treatments can disrupt sleep. Find out how treatments can affect sleep and what strategies you can use to sleep better.
Treatment and side effects
Immune effector cell-associated neurotoxicity syndrome (ICANS)
Updated:
Immune effector cell-associated neurotoxicity syndrome (ICANS) is a side effect that can happen after some forms of immunotherapy treatment. It may cause you to experience serious neurological symptoms.
Treatment and side effects
Myelofibrosis (MF) therapies: From palliation to disease modification - myeloproliferative neoplasms (MPN) conference 2025
Updated:
Dr. Vikas Gupta, Hematologist at the Princess Margaret Cancer Centre in Toronto, reviewed Myelofibrosis (MF) and the evolution in diagnosis, treatment options and aspects of follow-up care in this 1-hour webcast as part of MPN Conference 2025.
Myeloproliferative neoplasms
Understanding polycythemia vera (PV): Diagnosis, treatments and follow-up care - myeloproliferative neoplasms (MPN) conference 2025
Updated:
In this 1-hour live webcast, Dr. Sonia Cerquozzi, hematologist at the Tom Baker Cancer Center and Peter Lougheed Centre in Calgary, reviews PV, a type of MPN - its diagnosis, treatment options and aspects of follow-up care.
Myeloproliferative neoplasms